Neuro-Ophthalmology of Systemic Disease

ABSTRACT

Many neuro-ophthalmologic conditions may result from systemic disease or its treatments. This article provides an update on optic neuropathies, eye movement disorders, and intracranial visual pathway lesions that occur most commonly with systemic disease, are clinical emergencies, or have been identified or clarified in recent publications.

Ischemic optic neuropathy - idiopathic intracranial hypertension - paraneoplastic disorders - gaze palsy - metabolic optic neuropathy

REFERENCES

• 1 The Ischemic Optic Neuropathy Decompression Trial Research Group . Characteristics of patients with nonarteritic anterior ischemic optic neuropathy eligible for the Ischemic Optic Neuropathy Decompression Trial.  Arch Ophthalmol. 1996;  114 1366-1374
• 2 Beck R W, Servais G E, Hayreh S S. Anterior ischemic optic neuropathy. IX. Cup-to-disc ratio and its role in pathogenesis.  Ophthalmology. 1987;  94 1503-1508
• 3 Optic nerve decompression surgery for nonarteritic anterior ischemic optic neuropathy (NAION) is not effective and may be harmful.  The Ischemic Optic Neuropathy Decompression Trial Research Group . JAMA. 1995;  273 625-632
• 4 Preechawat P, Bruce B B, Newman N J, Biousse V. Anterior ischemic optic neuropathy in patients younger than 50 years.  Am J Ophthalmol. 2007;  144 953-960
• 5 Hayreh S S, Joos K M, Podhajsky P A, Long C R. Systemic diseases associated with nonarteritic anterior ischemic optic neuropathy.  Am J Ophthalmol. 1994;  118 766-780
• 6 Hayreh S S, Zimmerman M B. Incipient nonarteritic anterior ischemic optic neuropathy.  Ophthalmology. 2007;  114 1763-1772
• 7 Patel S V, Holmes J M, Hodge D O, Burke J P. Diabetes and hypertension in isolated sixth nerve palsy: a population-based study.  Ophthalmology. 2005;  112 760-763
• 8 Jacobson D M. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy.  Arch Ophthalmol. 1998;  116 723-727
• 9 Chou K L, Galetta S L, Liu G T et al.. Acute ocular motor mononeuropathies: prospective study of the roles of neuroimaging and clinical assessment.  J Neurol Sci. 2004;  219 35-39
• 10 Goh S Y, Ho S C, Seah L L, Fong K S, Khoo D H. Thyroid autoantibody profiles in ophthalmic dominant and thyroid dominant Graves' disease differ and suggest ophthalmopathy is a multiantigenic disease.  Clin Endocrinol (Oxf). 2004;  60 600-607
• 11 Eckstein A, Quadbeck B, Mueller G et al.. Impact of smoking on the response to treatment of thyroid associated ophthalmopathy.  Br J Ophthalmol. 2003;  87 773-776
• 12 Hayreh S S. Role of nocturnal arterial hypotension in the development of ocular manifestations of systemic arterial hypertension.  Curr Opin Ophthalmol. 1999;  10 474-482
• 13 Lee V H, Wijdicks E F, Manno E M, Rabinstein A A. Clinical spectrum of reversible posterior leukoencephalopathy syndrome.  Arch Neurol. 2008;  65 205-210
• 14 Covarrubias D J, Luetmer P H, Campeau N G. Posterior reversible encephalopathy syndrome: prognostic utility of quantitative diffusion-weighted MR images.  AJNR Am J Neuroradiol. 2002;  23 1038-1048
• 15 Jacobson D M. Lyme disease and optic neuritis: long-term follow-up of seropositive patients.  Neurology. 2003;  60 881-882
• 16 Bar S, Segal M, Shapira R, Savir H. Neuroretinitis associated with cat scratch disease.  Am J Ophthalmol. 1990;  110 703-705
• 17 Schwartz M A, Selhorst J B, Ochs A L et al.. Oculomasticatory myorhythmia: a unique movement disorder occurring in Whipple's disease.  Ann Neurol. 1986;  20 677-683
• 18 Averbuch-Heller L, Paulson G W, Daroff R B, Leigh R J. Whipple's disease mimicking progressive supranuclear palsy: the diagnostic value of eye movement recording.  J Neurol Neurosurg Psychiatry. 1999;  66 532-535
• 19 Sadun A A. Metabolic optic neuropathies.  Semin Ophthalmol. 2002;  17 29-32
• 20 Sadun A A. Mitochondrial optic neuropathies.  J Neurol Neurosurg Psychiatry. 2002;  72 423-425
• 21 Zuccoli G, Gallucci M, Capellades J et al.. Wernicke encephalopathy: MR findings at clinical presentation in twenty-six alcoholic and nonalcoholic patients.  AJNR Am J Neuroradiol. 2007;  28 1328-1331
• 22 Pittock S J, Kryzer T J, Lennon V A. Paraneoplastic antibodies coexist and predict cancer, not neurological syndrome.  Ann Neurol. 2004;  56 715-719
• 23 Cross S A, Salomao D R, Parisi J E et al.. Paraneoplastic autoimmune optic neuritis with retinitis defined by CRMP-5-IgG.  Ann Neurol. 2003;  54 38-50
• 24 Dalmau J, Graus F, Villarejo A et al.. Clinical analysis of anti-Ma2-associated encephalitis.  Brain. 2004;  127 1831-1844
• 25 Ko M W, Dalmau J, Galetta S L. Neuro-ophthalmologic manifestations of paraneoplastic syndromes.  J Neuroophthalmol. 2008;  28 58-68
• 26 Hayreh S S, Zimmerman B. Management of giant cell arteritis. Our 27-year clinical study: new light on old controversies.  Ophthalmologica. 2003;  217 239-259
• 27 Hayreh S S, Podhajsky P A, Zimmerman B. Occult giant cell arteritis: ocular manifestations.  Am J Ophthalmol. 1998;  125 521-526
• 28 Hayreh S S, Podhajsky P A, Raman R, Zimmerman B. Giant cell arteritis: validity and reliability of various diagnostic criteria.  Am J Ophthalmol. 1997;  123 285-296
• 29 Kupersmith M J, Burde R M, Warren F A, Klingele T G, Frohman L P, Mitnick H. Autoimmune optic neuropathy: evaluation and treatment.  J Neurol Neurosurg Psychiatry. 1988;  51 1381-1386
• 30 Fechner F P, Faquin W C, Pilch B Z. Wegener's granulomatosis of the orbit: a clinicopathological study of 15 patients.  Laryngoscope. 2002;  112 1945-1950
• 31 Zoumalan C I, Sadun A A. Optical coherence tomography can monitor reversible nerve-fibre layer changes in a patient with ethambutol-induced optic neuropathy.  Br J Ophthalmol. 2007;  91 839-840
• 32 Kardon R H, Morrisey M C, Lee A G. Abnormal multifocal electroretinogram (mfERG) in ethambutol toxicity.  Semin Ophthalmol. 2006;  21 215-222
• 33 Vistamehr S, Walsh T J, Adelman R A. Ethambutol neuroretinopathy.  Semin Ophthalmol. 2007;  22 141-146
• 34 Rucker J C, Hamilton S R, Bardenstein D, Isada C M, Lee M S. Linezolid-associated toxic optic neuropathy.  Neurology. 2006;  66 595-598
• 35 Javaheri M, Khurana R N, O'Hearn T M, Lai M M, Sadun A A. Linezolid-induced optic neuropathy: a mitochondrial disorder?.  Br J Ophthalmol. 2007;  91 111-115
• 36 Egan R, Pomeranz H. Sildenafil (Viagra) associated anterior ischemic optic neuropathy.  Arch Ophthalmol. 2000;  118 291-292
• 37 Cunningham A V, Smith K H. Anterior ischemic optic neuropathy associated with Viagra.  J Neuroophthalmol. 2001;  21 22-25
• 38 Nagra P K, Foroozan R, Savino P J, Castillo I, Sergott R C. Amiodarone induced optic neuropathy.  Br J Ophthalmol. 2003;  87 420-422
• 39 Danesh-Meyer H V, Levin L A. Erectile dysfunction drugs and risk of anterior ischaemic optic neuropathy: casual or causal association?.  Br J Ophthalmol. 2007;  91 1551-1555
• 40 Mindel J S, Anderson J, Hellkamp A et al.. Absence of bilateral vision loss from amiodarone: a randomized trial.  Am Heart J. 2007;  153 837-842
• 41 Purvin V, Kawasaki A, Borruat F X. Optic neuropathy in patients using amiodarone.  Arch Ophthalmol. 2006;  124 696-701
• 42 Shinder R, Frohman L P, Turbin R E. Regression of bilateral optic disc edema after discontinuation of amiodarone.  J Neuroophthalmol. 2006;  26 192-194
• 43 Cheng M A, Sigurdson W, Tempelhoff R, Lauryssen C. Visual loss after spine surgery: a survey.  Neurosurgery. 2000;  46 625-630 , discussion 630–621
• 44 Newman N J. Perioperative visual loss after nonocular surgeries.  Am J Ophthalmol. 2008;  145 604-610
• 45 Friedman D I. Medication-induced intracranial hypertension in dermatology.  Am J Clin Dermatol. 2005;  6 29-37
• 46 Solomon D, Ramat S, Tomsak R L et al.. Saccadic palsy after cardiac surgery: characteristics and pathogenesis.  Ann Neurol. 2008;  63 355-365
• 47 Eggers S D, Moster M L, Cranmer K. Selective saccadic palsy after cardiac surgery.  Neurology. 2008;  70 318-320
• 48 Singh N, Bonham A, Fukui M. Immunosuppressive-associated leukoencephalopathy in organ transplant recipients.  Transplantation. 2000;  69 467-472